US Patent Issued to ABTIS on June 23 for "Site-specific antibody conjugation and antibody-drug conjugate as specific embodiment thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,492, issued on June 23, was assigned to ABTIS Co. LTD. (Gyeonggi-do, South Korea).

"Site-specific antibody conjugation and antibody-drug conjugate as specific embodiment thereof" was invented by Sang Jeon Chung (Seoul, South Korea), Ju Hwan Kim (Gyeonggi-do, South Korea), Young Geun Lee (Gyeonggi-do, South Korea), Tae Jin Lee (Gyeonggi-do, South Korea) and Jin Woo Seo (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to technology capable of labeling a certain site of an antibody with a certain number of chemical functional groups or cargo moieties. The present invention may provide an antibody pr...